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ABSTRACT 
Using Electrochemical Method to Study the Interaction Between DNA and a compound Known 
to Have Anticancer Property 
by 
Alexander Kamasah 
The interaction of 4-(1’-[8’-(1’’-pyrenyl)naphthyl])-2,6-diaminopyridine bis-glycamide 
bishydrocholride known to have anticancer properties with deoxyribonucleic acid (DNA) had 
been studied on a modified gold electrode by self-assembled monolayer using cyclic 
voltammetry.  K4Fe (CN) ₆ was used as a probe to obtain electrochemical information on the 
electrode surface. 
   
A bare gold (Au) electrode was modified with cysteamine and our results showed no change in 
the limiting steady state current as compared to the bare Au electrode.  There was a reduction in 
the steady state current after the modification of the gold electrode with DNA.  Immobilization 
of the DNA modified gold electrode with the anticancer compound also revealed a further 
reduction in the steady state current.  The reduction in the steady state current is attributed to the 
receptor and DNA forming a nonelectrochemical complex due to the intercalation of the receptor 
and DNA on the gold electrode surface.  
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CHAPTER 1 
INTRODUCTION 
Cellular processes such as recombination, replication, transcription, and repair involve 
the interaction of DNA and protein.  Quiet a large number of the intracellular processes of 
living things rely on a distinctive and controlled interaction between nucleic acids and 
proteins [1].  Also, many of the proteins are involved in specific sequence DNA binding in 
the gene promoter region that regulates gene expression and maintenance [2].  The 
preciseness and potency of these interactions are controlled by the exact structure of the 
interacting molecule.  Apart from these specific interactions, there are other many proteins 
that bind in a non-specific way to nucleic acid and to other proteins [1].  There are certain 
organic molecules that bind to these DNA with high affinity and end up influencing its gene 
expression and therefore affect the cell proliferation.  Apart from these specific interactions, 
there are other many proteins that bind in a non-specific way to nucleic acid and to other 
proteins [3].  
The continuous exposure of DNA cells either by chemical or physical methods to 
chemicals destroy the viability of the cells [4].  If these impaired DNA bases are not repaired, 
it could cause mutation in the DNA cells [5] and can lead to the death of the cell by 
obstructing DNA replication [6].  It is of great significance to study damaged DNA surface 
because by doing so we would be able to identify early diagnostic of genetic deficiencies and 
detection of infectious diseases. [7, 8].  Quite a number of methods have been used to study 
the interaction between a DNA surface and a protein molecule some of which includes UV 
spectroscopy, electrochemical impedance spectroscopy, surface plasmon resonance, 
colorimetric, and electrochemical methods [9, 10].  Among these methods electrochemical 
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methods (using cyclic voltammetry) have been found to be the most convenient to use due to 
its high sensitivity, low cost characteristic, and compatibility with microarray technology.  
A very useful and efficient analytical tool is therefore needed to study these interactions 
between DNA and protein molecules as it would give us the opportunity to evaluate and 
predict possible anticancer drugs-DNA interactions.  In recent years a lot of studies on the 
properties of anti-carcinogenic drugs and their interactions with DNA are becoming more 
and more important in developing new cancer therapy treatment.  The study of these 
interactions between DNA and proteins is becoming more important due to the resemblance 
of electrochemical reactions and biological reactions such as oxidation mechanism taking 
place at the electrode surface and also those occurring in living organism [11]. 
  Electroanalytical analyst has adopted a better way of studying the surface properties and 
interactions between protein molecules and DNA.  This involves the use of a modified 
electrode because of its higher sensitivity and specificity as compared to the unmodified 
electrode.  The use of DNA modified electrode overcomes the limitations of other methods in 
large requirement for DNA samples and they also exhibit more useful electrochemical 
properties than the unmodified electrode [12]. 
 
Electrochemistry 
  Cyclic Voltammetry 
Cyclic voltammetry (CV) is a type of electrochemical technique that involves the 
potential of a stationary working electrode being changed linearly with time starting from a 
potential where no electrode reaction occurs and moving to potentials where reduction or 
oxidation of solute (the material being studied) occurs.  Cyclic voltammetry provides a simple 
correlation between experimental results and redox potential, diffusion coefficients, and rate 
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constant [13].   This type of technique is generally used to study the electrochemical properties 
of an analyte in solution and the analyte needs to be redox active within the experimental 
potential framework.  The analyte is electrolyzed (oxidized or reduced) by placing the solution in 
contact with the electrode surface and making that surface positive or negative in voltage to 
enhance electron transfer.  The transfer of electrons or the flow of current comes about when the 
potential of the electrode which is very positive of the formal potential of the electrode (E
O
) and 
it is adjusted negatively, then reduction begins once the potential reaches the vicinity of (E
O
).  A 
rapid increase in current occurs, as the surface concentration of the reactive species becomes 
smaller.  The current will increase as the potential reaches the reduction potential of the analyte 
but then falls off as the concentration of the analyte is depleted close to the electrode surface. 
A reversal of the potential to a more positive value causes the reduced species to be 
oxidized as the current moves towards (E
O
). A graph of current (I) against voltage (v) can be 
plotted and two measured parameters that is the ratio of the peak currents (Ipa/Ipc) and the 
separation of the peak potential Epa-Epc can be obtained. [5]. An example of cyclic voltamogram 
is shown in Figure1. 
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Figure 1: A cyclic voltammogram for a bare gold electrode. The anodic and cathodic peak current 
has been indicated by Ipa and Ipc respectively 
 
The magnitude of the peak currents, that is Ipa and Ipc and the potential at which the various 
peaks occur (Epa and Epc), are the most important parameters of cyclic voltammetry[14].  In cyclic 
voltammetry, three types of electrodes are used and these are the working electrode, reference 
electrode, and the auxiliary or counter electrode [15].   All the electrodes are then placed in a glass 
vial that is filled with a redox probe solution and the whole system is referred to as an 
electrochemical cell. A typical electrochemical cell has been illustrated in Figure 2. 
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                                                                                                                             Counter electrode     
           Working electrode 
           Reference electrode                                                                                                                       
  
 
                                                                                                                                            
                                                                                     
                                                                                                                        
 
Electrolyte solution 
 
 
Figure 2: A general diagram of an electrochemical cell, showing the three electrodes system  
     employed in cyclic voltammetry 
The working electrode is the electrode in electrochemical system on which the reaction of 
interest is occurring.  The working electrode can either be cathodic or anodic depending on whether 
the reaction on the electrode is oxidation or reduction.  The counter electrode is usually made of an 
inert material such as platinum wire that simply serves to conduct electricity from the signal source 
through the solution to the other electrodes.  The counter electrode often has a large surface area that 
is much larger than that of the working electrode to ensure that the half reaction occurring at the 
counter electrode can take place faster so as not to limit the process at the working electrode.  The 
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reference electrode consists of a piece of silver wire that is coated with AgCl.  The reference 
electrode is always at a known potential; this constant potential value offers a standard against which 
to measure the working electrode potential [16]. 
Immobilization of DNA on Gold Surfaces 
Quiet a number of techniques have been postulated to explain the surface-immobilization of 
DNA on electrodes and among such methods include chemical adsorption [17, 18], covalent binding 
[19, 20, 21], electrostatic attraction [22, 23, 24], and co-polymerization [25].  As a result of the 
unprecedented growth in the development of electrochemical DNA biosensors, it would be of great 
importance to seek for new methods of surface-immobilization on gold electrode surface to improve 
upon the sensitivity of a DNA biosensor.  
Two ideal techniques have been found to be useful for DNA surface modification on 
electrode and these are Self-assembly monolayer (SAM) and Layer by Layer method. 
Self-Assembly Monolayer (SAM) 
 The formation of self-assembled monolayers involves the presence of a bifunctional linker 
such as cysteamine that serves as a means to bind the DNA to an electrode surface.  It involves a 
layer of material that binds to a given surface in an ordered form due to chemical or physical forces. 
The length of alkyl chains present in alkanethiols determines the rate of electron transfer processes. 
Longer chains show a great resistant in electron transfer as compared to shorter alkane chains [26, 
27].  Figure 3 illustrates the formation of self-assembled monolayer (SAM). 
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Figure 3: An illustration of a self-assembled DNA monolayer on a gold electrode   
Layer by Layer Method 
 The layer by layer method enables multiple layers to form on a gold electrode.  This is 
achieved by the immersion of gold electrode in a solution containing cysteamine.  The 
cysteamine forms a positive charge monolayer on the gold electrode which then makes it 
possible for the negatively charged phosphate backbone of the DNA to be attached to it through 
electrostatic force of attraction. Another positively charged compound can then be immobilized 
as shown in Figure 4 [28]. 
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 Figure 4: Schematic diagram showing layer by layer assembly method 
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Structure of DNA 
A single strand of DNA is made up of a series of nucleotides.  Nucleotides are made up 
of a nitrogenous base, a phosphate group and a 5- carbon sugar (pentose).  The nitrogenous base 
together with the pentose is called nucleoside.  There are four types of nucleotides found DNA, 
differing only in the nitrogenous base, and these bases are purines: which consists of adenine (A) 
and guanine (G), or pyrimidines: which also consists of thymine (T) and cytosine (C).  In both 
DNA and RNA one of the pyrimidines is cytosine (C), and the other important pyrimidine is 
thymine (T) that is basically found in DNA and uracil (U) also found in RNA.  The DNA 
molecule consists of two strands that form a double helix by coiling around its axis.  The strands 
are antiparallel in nature and that demonstrates its 5’,3’-phosphodiester bonds moves in opposite 
directions. On the outside of the double helix are negatively charged phosphate groups and the 
hydrophilic regions of the pentoses.  The hydrophobic regions of the bases are inside the double 
helical structure of the DNA.  The complementary nature of the interactions between the two 
strands of a DNA helix is determined by the base present on each strand.  The conformation of 
the two strands creates two types of grooves called the major groove and the minor groove in 
each base pair.  The major and minor groove can be of different sizes depending on the 
conformation of DNA and can be important structural determinants in the interactions between 
DNA and proteins.  The structure of DNA presents a variety of sites where ligands or small 
molecules may interact to bind to the DNA. The major categories of non-covalent binding to the 
DNA are ionic interactions with the phosphate backbone, hydrophobic intercalative binding with 
the bases, and mixed interactions with the major or minor grooves [32].   Examples of the 
various nitrogenous bases and the interaction between Adenine and Thymine are shown in 
Figures 5 and 6 respectively.  
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 Adeninie   Guanine    Thymine  
                                
  Cytosine                                                                                      Uracil   
                                                                                            
Figure 5:  Structures of adenine, guanine, cytosine, thymine, and Uracil                           
                   
                          Adenine                                         Thymine                                                                                                                                                                                                                                                                                               
 Figure 6: Base pairing between adenine and thymine 
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In nucleic acids two types of ribose can be identified, and these are deoxy-D-ribose of the 
DNA and D-ribose from RNA.  The two types of ribose in DNA and RNA are five membered 
cyclic rings, with the difference being the substituent at carbon 2.  The two types of ribose are 
shown in Figure 7. 
 
                             
           D-Ribose (in RNA)                                  2’Deoxy-D-Ribose (in RNA) 
 Figure 7: An illustration of the two forms of ribose 
DNA  exist in living organisms as a pair of molecules held tightly together and they 
entangle into each other to form a double helix that is stabilized by hydrogen bonding between 
the nucleotide and base-stacking interactions among the aromatic bases [32].  Long chain of 
nucleotides of DNA and RNA is due to the presence of covalent bond through phosphate-group 
bridges that link the nucleotides together.  This involves the joining together of a 5’-hydroxyl 
group of one nucleotide with a 3’-hydroxyl group of the next available nucleotide [33]. 
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Uracil 
Uracil is widely known to occur naturally as a pyrimidine derivative [34].  It is found in 
ribonucleic acid RNA and it base-pairs through hydrogen bonding with adenine and takes the 
place of thymine throughout the process of DNA transcription. Uracil can be converted to 
thymine through methylation that has been found to improve the efficiency of DNA replication.  
Uracil has the potential to bind with a ribose sugar to produce ribonucleoside uridine [35].  D.J 
Brown and his group investigated on the tautomeric property of uracil and they came up with 
amide-imidic acid tautomeric shift.  The amide tautomer is known as the lactam structure, while 
the imidic acid tautomer is also called lactim structure.  The tautomeric forms of the uracil are 
predominant at pH 7 and the lactam structure was found to be the most common form of uracil 
[36].  The tautomeric form of uracil is shown in Figure 8. 
 
             
        Imide        Lactim 
Figure 8: A schematic illustration of tautomers of uracil 
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Uracil can undergo degradation to produce compounds such as carbon dioxide, ammonia, 
and aspartate.  Uracil can also undergo oxidative degradation to produce urea and maleic acid in 
the presence of peroxides and Fe
2+ 
[34].  Gishan et al. and his group had been reported to 
synthesize uracil in the laboratory, the simplest of them being addition of water to cytosine to 
produce uracil and ammonia [35].   
C4H5N3O + H2O                               C4H4N2O2 + NH3    Equation 1 
The most commonly used method in synthesizing uracil involves the condensation of maleic acid 
with urea in fuming sulfuric acid [36].  In recent times uracil and its derivatives had been studied 
due to the role that they play during molecular recognition, more importantly uracil and thymine 
had been found to have relation to human diseases and cancers [37].  Figure 9 illustrates the 
various derivatives of uracil. 
 
                 
5-Formyluracil (5FoU) 5-Fluorouracil (5FU)            5-Nitrouracil (5FNiU) 
Figure 9: Structures of the derivatives of uracil 
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5-Fluorouracil (5-FU) had been found to be very useful diagnosing cancers, also uracil 
and 5-formyluracil are widely known due to their ability to damage DNA bases while 5-
Nitrouracil (5-NiU) are also known to exhibit some antiviral properties because they are able to 
inhibit thymidylate synthetase [38].  5-Flurouracil (5-FU) has been increasingly used alone or in 
combination with other various cytoxic drugs and hormones in treating some tumors such as 
breast, colorectal, and gastric cancers [39].  5-Flurouracil has been found to exhibit poor tumor 
selectivity and high incidence of toxicity in the bone marrow, skin, and the central nervous 
system [40-43]. 
Drug -DNA Interactions 
The interaction of small molecules including drugs with DNA can either be specific or 
non-specific.  For non-specific interactions, the sequence of nucleotide is not all that important, 
as far as the binding interactions are concerned.  However, specific DNA-protein interactions 
depend upon the sequence of bases in the DNA (orientation of the bases).  These protein-DNA 
interactions are normally controlled by three major forces (a) hydrogen bonding, (b) ionic 
interactions, (c) other forces such as Van der Waals.   The interactions of protein molecules with 
DNA including drugs have generated lot of interest from biological scientist and pharmaceutical 
analyst. For some years now there has been an increasing concern to understand the active 
mechanisms of some anticancer drug and their carcinogenic compounds and to come up with 
DNA-targeted drug. Interactions of DNA with some anticancer drugs occurs via three different 
methods (a) the first being under the control of transcription factors and polymerases that drug 
interacts with proteins that bind to DNA, (b) the second being small aromatic compounds that 
bind to the DNA double helical structure and (c) lastly through RNA binding to the DNA double 
helix that brings about suppression of the transcription activity [44].  
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A very common interaction that is observed in DNA-protein is between an arginine 
residue on the protein and a guanine residue as illustrated in Figure 10.  A specific combination 
of several intermolecular interactions between residues of a given protein and a given DNA 
sequence will ensure a particular protein only binds tightly to a particular DNA sequence to 
which it is targeted.  The higher the number of point’s contacts that exist between the DNA 
sequence and the protein, the more specific the interaction becomes [45].  Certain antibodies or 
DNA-binding molecules such as Bovine serum albumin (BSA) showed no modification of signal 
with DNA monolayer.  This phenomenon was attributed to the fact that no interaction was 
observed between BSA and the DNA because of the repulsion between their negative charges 
[46].  The overall charge of Bovine serum albumin is -18 but after methylation of the compound 
under acidic conditions produces methylated BSA (me-BSA) [47] that has a positive charge of 
8.5 [48].  The DNA with a negative charge is then able to bind with the me-BSA through ionic 
interactions.  Figure 10 illustrate how argentine residue and guanine residue interact through 
hydrogen bonding. 
  
Figure 10: An illustration of the interaction between an arginine residue and guanine residue              
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Barton et al. [46] used an electrochemical assay of protein binding to a modified DNA 
electrode based upon detection of disturbances in DNA base stacking.  They modified the gold 
surface with loosely packed DNA stands and covalently crosslinked it to a redox-active 
intercalator containing the binding sites of the test protein.  A considerable reduction in current 
was observed in the presence of base-flipping enzyme Hhal methylase and uracil DNA 
glycosylase due to charge transfer between the DNA and the protein that causes some 
disturbances on the DNA strand. 
Drug Used for Immobilization 
4-(1’-[8’-(1’’-Pyrenyl)naphthyl])-2,6-diaminopyridine Bis-glycamide Bishydrocholride  
(receptor) has been found to mimic the active site in uracil DNA glycosylase (UDG).  UDG is 
responsible for pulling unwanted uracil into its active site through hydrogen bonding or      
during DNA repair processes.  The drug has been found to bind selectively to uracil and its 
derivatives and also some DNA and RNA nucleosides.  The 2,6-bis(glycylamino)pyridinyl group 
in the drug was found to be responsible for mimicking the amino acid residues in UDG that 
participate in hydrogen bonding and also the presence of a pyrenyl group mimics the phenyl 
group that undergoes      stacking interactions in the active site of UDG [49].  The drug to be 
used to for immobilization is shown in Figure 11. 
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Figure 11: A chemical structure of the receptor binding with uracil used in immobilization 4-(1’-
[8’-(1’’-pyrenyl)naphthyl])-2,6-diaminopyridine bis-glycamide bishydrocholride 
Research Objective 
The main aim of this research is to design, construct, and study the interaction between 
DNA and (4-(1’-[8’-(1’’-pyrenyl)naphthyl])-2,6-diaminopyridine bis-glycamide 
bishydrocholride) known to have anticancer properties using electrochemical technique.  A 
monolayer of double stranded or single stranded DNA of a particular sequence was bound to the 
surface of gold electrode.  Cyclic voltammetry was used to characterize the DNA monolayer on 
the gold surface.  After the characterization of the DNA monolayer, it was then placed in a 
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solution for about 30 minutes containing the drug that had been dissolved in a buffer solution.  
Again cyclic voltammetry was used to study the interaction between the modified DNA 
electrode and the anticancer compound by observing the various changes in the voltammogram 
and then correlating it with literature values. 
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CHAPTER 2 
EXPERIMENTAL PROCEDURE 
List of Chemicals 
 All aqueous solutions were made using demineralized water. 2-aminoethanethiol 
hydrochloride was obtained from Sigma Aldrich (St. Louis, MO) Calf thymus double stranded DNA 
was also obtained from Sigma Aldrich (St. Louis, MO), Potassium Nitrate (KNO3) was also 
obtained from Fischer Scientific (NJ, USA) and was used as supporting electrolyte.  All the 
chemicals, unless otherwise mentioned, were of analytical grade and were used as received. 
Preparation of Electrodes 
A piece of Au wire was slotted into conical shaped capillary tube that was then placed in a 
heating coil in order to close one of its ends.  A vacuum pump was then connected to the other open 
end of the capillary tube in order to remove air trapped in the tube. An electrical connection was then 
made to the gold wire by connecting a copper wire to it, after which a little amount of torr seal 
epoxy was applied to the open end of the glass capillary in other to seal the tube and also provide 
an electrical connection.  The connection between the gold and the copper was verified using a 
microscope.  The gold electrodes were then polished to a mirror-like surface with aluminum slurry 
on a polishing pad followed by rinsing with deionized water until the surface was smoothed and 
unscratched.  The surface smoothness was verified again with a microscope.   
Instrumentation 
Cyclic voltammetry (CV) system consisting of four components was used for the experiment.  
These components were (a) electrolysis cell: that consists of the working electrode, counter electrode, 
reference electrode, and the electrolytic solution.  The working electrode potential was varied linearly 
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with time, while the reference electrode was maintained at a constant potential. The counter electrode 
conducted electricity from the signal source to the working electrode.  The electrolytic solution 
served as a source of ions generation needed at the electrode during the process of oxidation and 
reduction. (b) An electrical device called potentiostat that uses a dc power to generate a potential that 
is determined correctly, while allowing little amount of currents to be drawn into system without 
altering the voltage. (c) A current-voltage converter that measures the resulting current and (d) data 
acquisition system responsible for generating the voltammogram. 
Electrochemical measurements (cyclic voltammetry) were carried out in a three-electrode 
system that consisted of a counter electrode made of platinum, a reference electrode, and a modified 
working electrode.  The electrochemical measurements were carried out in a 10 mL glass cell at 
room temperature.  The electrodes entered the 10 mL glass vial through holes that were created in the 
vial lid cover.  The real electrode area was estimated from cyclic voltammogram (CV) by integrating 
the cathodic peak for the reduction of the oxide layer in 0.5 M H2SO4.  The freshly prepared 
electrodes were scanned until a constant voltammogram was obtained 
Preparation of Cysteamine Solution 
The cysteamine solution used for all the experiments were freshly prepared by dissolving 
0.2840 g of 2- aminoethanethiol hydrochloride in 25 mL of ethanol solution to obtained a 0.1 M 
cysteamine solution.  Prior to the use of the cysteamine solution it was kept in a refrigerator. 
Preparation of Redox Probe Solution 
The redox probe solution used for all the experiments was freshly prepared by using an 
analytical balance to weigh 0.0211 g of potassium ferrocynide and transferring it into a 50 mL 
volumetric flask.  This was followed by weighing again 0.5055 g of potassium nitrate serving as a 
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supporting electrolyte and transferring it into the 500 mL volumetric flask containing the potassium 
ferrocynide.  Distilled water was used in preparing this redox probe solution. 
Preparation of DNA Solution 
Stock solution of 0.1 M H3PO4/ NaH2PO4 buffer solution at pH 7.0 was prepared in a 500 mL 
volumetric flask and kept in the refrigerator.  The prepared buffer solution was then used to prepare 
the DNA solution to be used for the immobilization and this was achieved by dissolving 1 g/L of the 
ds DNA in 50 mL of the buffer solution.  The solution was stirred for about 2 hours until a uniform 
mixture was obtained. 
Cysteamine- Modified Gold Electrode 
Modification of the freshly prepared electrode was done by soaking the bare gold 
electrode (GE) in a 0.1 M freshly prepared cysteamine solution for 24 hours at room temperature 
in other to form a monolayer of cysteamine.  The cysteamine modified gold electrodes were then 
thoroughly rinsed with ethanol and distilled water to remove physically adsorbed cysteamine. 
The modified electrodes were then characterized by scanning it in a 1 mmol of the freshly 
prepared probe solution (K4Fe (CN) ₆) using potassium nitrate (KNO3) serving as the supporting 
electrolyte and also in 0.5 M H2SO4 solution. 
DNA-Modified Gold Electrode 
The modified cysteamine gold electrodes were then placed in the DNA solution for 24 
hrs containing 0.1 M NaHPO4/H3PO4 buffer of pH 7 and then thoroughly rinsed with the 
phosphate buffer solution to remove physically adsorb DNA.   The modified cysteamine/DNA 
electrodes were then characterized in K4Fe (CN) ₆ using Ag/AgCl as reference electrode at scan 
rate 100 mV/s obtain the voltammogram. 
30 
 
Immobilization of Drug on DNA-Modified Electrode 
 Finally, the modified DNA gold electrodes were immersed in an aqueous solution 
containing the drug solution for 30 minutes and cyclic voltammogram were obtained in 1 mmol 
of  k4Fe (CN) ₆ and 0.1 M KNO3 as the supporting electrolyte. 
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CHAPTER 3 
RESULTS AND DISCUSSION 
 This chapter talks about the results obtained in the form of voltammogram carried out in our 
redox probe solution, sulphuric acid, cysteamine solution, DNA solution, and our drug solution.  This 
chapter further discusses the various changes recorded in the peak current after the modification of 
the electrode. 
Characterization of the Bare Gold Electrode 
 The fabricated gold electrodes were characterized by obtaining cyclic voltammogram in 0.5 
M H2S04 using Ag/AgCl reference electrode at a scan rate of 100 mV/s as shown in Figure 12.  The 
oxidation of the gold produced a well defined peak at 1.18 V and cathodic peak was also observed at 
0.75 V representing the reduction of the gold (Au) from +3 to 0 state.  The oxidation reaction 
occurring at the gold electrode surface is given by the equation 
Au  - 3e                                       Au3+        Equation 2 
The cyclic voltammogram obtained after the characterization is shown Figure 12.   
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Figure 12: cyclic voltammogram on a bare gold electrode scanned in 0.5 M H2S04 using Ag/AgCl 
reference electrode at scan rate 100 mV/s 
 Further characterization of the bare gold electrodes were carried out in 1mmol K4Fe (CN) ₆ 
using Ag/AgCl reference electrode in a potential range from 5 V to -2 V using a scan rate of 100 
mV/s.  The cyclic voltammogram shown in Figure 13 shows that K4Fe (CN) ₆ species on the gold 
electrode surface has been oxidized.  The equation below represents the oxidation of the 
ferrocyanide species on the gold electrode surface.  
             Fe(CN) 6
4 -   
-e             Fe(CN)6
3-            Equation 2 
Ideally at any scan rate we expect to have a well shaped voltammogram that has a flat 
plateau that demonstrates there is no presence of charging current.  The shape of the 
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voltammogram in Figure 13 revealed a rather big charging current that is attributed to the gap 
between the  glass insulation layer and the gold electrode.    
 
Figure 13: Cyclic voltammogram obtained on a bare gold electrode scanned in 1mmol of 
 K4Fe (CN)₆ using Ag/AgCl reference electrode at scan rate 100 mV/s 
Steps were taken to reduce the charging current by placing the electrodes vertically in a 
hot liquefied wax for sometime so as to seal the gap upon drying.   The electrodes were then 
polished so as to remove wax that might have covered the area of interest at the tip of the 
electrode.   Cyclic voltammetry was carried out on the electrodes but the presence of the 
charging current still persisted. 
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Characterization of Cysteamine Modified Gold Electrode 
The characterization of the cysteamine modified gold electrode was done by obtaining 
cyclic voltammogram in 1 mmol K4Fe (CN) 6 within a potential range of -0.2 V to 0.5 V using a 
scan rate of 100  mV/s.  The voltammogram is shown in Figure 14.   Electrochemical reaction 
that occurred after the immobilization of the bare gold electrode with cysteamine, revealed 
apparently no change in the magnitude limiting steady state current, compared to the bare gold 
electrode although the reaction still produced a reduction Fe (CN) 6
4+ 
to Fe (CN) 6
3+
.   This 
phenomenon can be attributed to the fact that cysteamine which is made up of short alkanethiol 
provides an insufficient barrier to block the process of electron transfer between the electrode 
surface and the probe solution.  This then enables most of the redox species in solution to get 
access to the gold electrode surface. 
 
Figure14: Cyclic voltammogram obtained on a cysteamine monolayer modified gold electrode in 
solution containing 1mmol  K4Fe (CN) ₆ with Ag/AgCl serving as reference electrode at a scan 
rate of 100 mV/s 
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Characterization of DNA/ Cysteamine/ Bare Gold Electrode 
The characterization of the DNA/ Cysteamine/ Bare gold electrodes was done by 
obtaining cyclic voltammogram in 1 mmol K4Fe (CN)₆ as shown in the Figure 15. 
 
Figure15: Cyclic voltammogram obtained on Bare gold electrode (A), cysteamine modified electrode 
(B) and DNA modified electrode (C)  in 1 mmol of K4Fe(CN)₆ at a scan rate of 100 mV/s  
Figure15 clearly shows a drastic reduction in the limiting steady state current observed 
after the modification of the electrode with DNA compared to those of the cysteamine and the 
bare gold electrode.  The obvious reduction in the limiting steady state current is attributed to the 
DNA acting as a mass transfer blocking layer and thereby hindering the diffusion of ferricyanide 
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species towards the electrode surface.  This observation shows that the DNA has been 
successfully assembled on the cysteamine gold electrode surface. 
Immobilization of Drug on DNA-Modified Electrode 
 The modified DNA/ cysteamine/ bare gold electrode was placed into an aqueous solution 
of the drug solution for about 25 minutes followed by scanning it in 1 mmol M K4Fe(CN)₆ using 
Ag/AgCl as a reference electrode at scan rate 100 mV/s. 
 The cyclic voltammogram showed a further reduction in the limiting steady current of the 
redox probe after the modified DNA electrode was immersed in the receptor solution as shown 
in Figure16.   
 
Figure 16: Cyclic voltammogram obtained on Bare Au electrode (A), Cysteamine modified (B), 
DNA modified electrode, (C) and Drug modified electrode, (D) in 1 mmol K4Fe(CN)₆  at scan 
rate 100 mV/s 
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From the voltammogram in Figure 16, electrode (D) showed a further reduction in the 
limiting steady state current after the immobilization. The reduction in the limiting steady state 
current of electrode (D) can be attributed to electrostatic interaction between the DNA and the 
drug (4-(1’-[8’-(1’’-Pyrenyl) naphthyl])-2, 6-diaminopyridine Bis-glycamide Bishydrocholride) 
forming an inert complex that prevent the electroactive species from reaching the electrode 
surface and that induces the decrease of the electrochemical response due to the receptor binding 
to the DNA by intercalation.  The intercalation process involves the compound finding itself 
stack in between the adjacent DNA pairs.   Research by Jiang et al.[49] found out that (4-(1’-[8’-
(1’’-pyrenyl) naphthyl])-2, 6-diaminopyridine bis-glycamide bishydrocholride) has the potential 
to detect and recognized damaged DNA and bases [49]. 
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CHAPTER 4 
CONCLUSION AND RECOMMENDATION 
 In this research, the electrochemical behavior of the receptor (4-(1’-[8’-(1’’-pyrenyl) 
naphthyl])-2, 6-diaminopyridine bis-glycamide bishydrocholride) and its interaction with a 
modified DNA was investigated using electrochemical method. All the experimental results 
agreed with expectations. In summary, the following conclusions were drawn from this research: 
a. A modified DNA electrode was fabricated successfully using self-assembled 
monolayer  method 
b. Cyclic voltammetry have been used to characterized the modified electrode surface 
c. The results obtained indicate that, the principal interaction mode of (4-(1’-[8’-(1’’-
pyrenyl) naphthyl])-2, 6-diaminopyridine bis-glycamide bishydrocholride) with DNA 
is by intercalative interaction. 
Because the results obtained demonstrate that cyclic voltammetry provides an efficient 
method to study the mechanism of DNA interaction with a compound, it would be very useful if 
the interaction can be quantified using spectrophotometry method. 
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